ADL Farmaceutici Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
- Investments
-
2
ADL Farmaceutici General Information
Description
Developer of pharmaceutical products intended to contribute to the well-being of patients through the development and marketing of nutraceuticals, dermo-cosmetics, and medical devices. The company formulates a wide range of products for gynecology, pediatrics, urology, dermatology, MMG, and respiratory uses, enabling the medical profession and patients to ensure maximum efficacy, safety and tolerability.
Contact Information
Website
www.adlfarmaceutici.comCorporate Office
- Altamira Complex
- Via Pisciarelli, 79
- 80078 Pozzuoli(Casalnuovo of Naples)
- Italy
Corporate Office
- Altamira Complex
- Via Pisciarelli, 79
- 80078 Pozzuoli(Casalnuovo of Naples)
- Italy
ADL Farmaceutici Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ADL Farmaceutici Patents
ADL Farmaceutici Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4401687-A1 | Endovaginal device for the correction of bladder and uterine prolapse incorporating a self-washing system with vaginal douches | Active | 15-Sep-2021 | ||
| EP-4401687-B1 | Endovaginal device for the correction of bladder and uterine prolapse incorporating a self-washing system with vaginal douches | Active | 15-Sep-2021 | ||
| EP-4401687-C0 | Endovaginal device for the correction of bladder and uterine prolapse incorporating a self-washing system with vaginal douches | Active | 15-Sep-2021 | ||
| WO-2023041956-A1 | Endovaginal device for the correction of bladder and uterine prolapse incorporating a self-washing system with vaginal douches | Inactive | 15-Sep-2021 | ||
| WO-2022003592-A1 | Improved nasal atomizer | Inactive | 01-Jul-2020 | A61M11/007 |
ADL Farmaceutici Signals
ADL Farmaceutici Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ADL Farmaceutici Investments & Acquisitions (2)
ADL Farmaceutici’s most recent deal was a Joint Venture with ADL Unilab. The deal was made on 20-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ADL Unilab | 20-Mar-2024 | Joint Venture | Media and Information Services (B2B) | ||
| Pharma Mum Italia | 05-Dec-2023 | Merger/Acquisition | Other Consumer Non-Durables |
ADL Farmaceutici Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pharma Mum Italia | Milan, France |
ADL Farmaceutici FAQs
-
When was ADL Farmaceutici founded?
ADL Farmaceutici was founded in 2012.
-
Where is ADL Farmaceutici headquartered?
ADL Farmaceutici is headquartered in Pozzuoli, Italy.
-
What is the size of ADL Farmaceutici?
ADL Farmaceutici has 23 total employees.
-
What industry is ADL Farmaceutici in?
ADL Farmaceutici’s primary industry is Pharmaceuticals.
-
Is ADL Farmaceutici a private or public company?
ADL Farmaceutici is a Private company.
-
What is ADL Farmaceutici’s current revenue?
The current revenue for ADL Farmaceutici is .
-
How much funding has ADL Farmaceutici raised over time?
ADL Farmaceutici has raised $1.8M.
-
Who are ADL Farmaceutici’s investors?
Arterra Bioscience has invested in ADL Farmaceutici.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process